The US Supreme Court has blocked significant restrictions on access to the abortion pill mifepristone, allowing it to continue being accessed by mail. The ruling came after two manufacturers of the pill asked the high court to intervene in an ongoing lawsuit. This decision will likely keep access to the pill open until the lawsuit is decided, potentially next year.
The case involves a lawsuit filed by the state of Louisiana against the Food and Drug Administration (FDA), which had allowed doctors to send mifepristone by mail or through pharmacies using telemedicine. Louisiana argued that this interfered with its own abortion ban. An appeals court had temporarily reinstated a requirement for in-person pickup of the pill, prompting the manufacturers to ask the Supreme Court to step in.
Abortion Pill Access
Mifepristone is the most common method of terminating pregnancies in the US, particularly in states where abortion is banned. The FDA had allowed the pill to be sent by mail since 2023, after initially lifting the in-person dispensing requirement during the Covid-19 pandemic. The Supreme Court’s decision to block restrictions on mifepristone access is significant, given that over 20 US states have banned or restricted abortion since the high court overturned Roe v Wade in 2022.
The Supreme Court’s most conservative justices, Clarence Thomas and Samuel Alito, dissented from the decision, with Thomas arguing that the manufacturers are not entitled to block a court order based on lost profits from their “criminal enterprise” in Louisiana. The ruling, which is a stay, will remain in place until the justices decide whether to hear the manufacturers’ case.
Implications and Reactions
The decision has significant implications for access to abortion in the US, particularly in states with strict abortion laws. The ruling may also have an impact on the ongoing debate over abortion rights in the country. As the lawsuit continues to play out, the Supreme Court’s decision to block restrictions on mifepristone access will likely be closely watched by abortion rights advocates and opponents alike.
The case highlights the ongoing challenges to abortion access in the US, particularly since the Supreme Court overturned Roe v Wade. The decision to block restrictions on mifepristone access is a significant development in the ongoing debate over abortion rights, and its impact will be felt across the country.
